Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MLTX
MLTX logo

MLTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MLTX News

CFO Sells 39,120 Shares of MoonLake Immunotherapeutics

4d agoFool

MoonLake CFO Sells Shares Amid Market Volatility

4d agoNASDAQ.COM

MoonLake Immunotherapeutics Shares Drop Amid Secondary Offering

Jun 25 2026Fool

MoonLake Aims to Raise $200 Million to Support Drug Development

Jun 25 2026NASDAQ.COM

MoonLake Immunotherapeutics Upsizes Offering to $200 Million Amid Strong Phase 3 Data

Jun 24 2026stocktwits

MoonLake Immunotherapeutics Prices $200M Public Offering

Jun 24 2026seekingalpha

MoonLake Immunotherapeutics Prices $200 Million Upsized Public Offering

Jun 24 2026NASDAQ.COM

MoonLake Immunotherapeutics Prices Public Offering at $20 per Share

Jun 24 2026Newsfilter

MLTX Events

06/24 06:30
Deal Size Increased to $200M
The deal size was increased to $200M in common stock and prefunded warrants from $150M. Leerink, Guggenheim, Cantor Fitzgerald and LifeSci Capital acted as joint book running managers for the offering.
06/22 20:00
Tech Stocks Weighed Down, Nasdaq Falls Over 1%
Turmoil in the mega-cap tech space and higher interest rates weighed on investor sentiment on Monday as markets returned from an extended weekend.  Six of the seven MAG-7 stocks were down, and even Tesla- the sole gainer - scrambled amid headlines of fatal FSD crashes.  Double-digit decline in SpaceXshares following the company's announcement of a debt offering this morning further weighed on tech-heavy Nasdaq, which finished the day down over 1%.In the opening hours of the evening session, investor sentiment is muted, with S&P 500 futures down to 10 and Nasdaq 100 down 0.3%.  In addition to the headline roulette regarding negotiations over the cost of a safe passage through the Strait of Hormuz, earnings out of Micronon Wednesday evening and PCE inflation data expected out Thursday morning are the key risk events for the week.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER -Avis Budget Groupup 6.5% after settlement agreement with Pentwater CapitalMurphy Oilup 1.0% after disclosing oil discovery offshore Côte d'IvoireLOWER -Primoris Servicesdown 33.4% after cutting FY26 guidanceDefinium Therapeuticsdown 4.6% after equity offeringMoonLake Immunotherapeuticsdown 3.8% after equity offeringGloo Holdingsdown 2.6% after equity offering
06/22 16:30
MoonLake Proposes Public Offering of $150M Shares
MoonLake Immunotherapeutics announced a proposed public offering of $150M of its Class A ordinary shares and, in lieu of Class A ordinary shares to certain investors that so choose, pre-funded warrants to purchase Class A ordinary shares. All of the securities to be sold in the offering are being offered by MoonLake. Leerink Partners, Guggenheim Securities, Cantor and LifeSci Capital are acting as joint bookrunning managers for the offering.
06/22 16:30
Nasdaq Declines Amid Weakness in Tech Stocks
The major averages had a mixed finish, with the Nasdaq the loser amid weakness in technology stocks, most notably SpaceX. Peace negotiations between the U.S. and Iran have reportedly shown progress, helping push oil prices lower and reducing some of the inflation pressure that had worried investors in recent weeks. Of note, U.S. Treasury Secretary Scott Bessent said in a social media post that the Treasury Department has issued a temporary 60-day license to allow Iran to sell oil.At the same time, attention is shifting back toward the Federal Reserve and the possibility that rates stay elevated for longer. Markets this week are closely watching upcoming inflation data, particularly the PCE reading, as recent commentary has reinforced expectations that policymakers remain focused on controlling inflation rather than supporting asset prices.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Chevronwith Microsoftto power a data center in West TexasCRHArcosafor $150 per share in cashAbbVieApogee Therapeuticsfor $135.11 per share in cash, or $10.9BSpaceXhas signed a computing power deal with Reflection worth up to $6.3B,Texas AG Ken Paxtoninto Carnivalfollowing the company's April data breach2. WALL STREET CALLS:SpaceXwith a Sector Weight at KeyBancVisteonat JPMorgan and BarclaysRoth Capitala handful of exploration and production names, saying oil prices are close to a near-term bottomAccentureto Hold at TD CowenTE Connectivityto In Line at Evercore ISI3. AROUND THE WEB:Metais planning a $900M investment in Indian fintech startup Cred for a roughly 20% stake, alongside plans to appoint Cred founder Kunal Shah as the new leader of WhatsApp, Bloomberg' reportsBaldwin Groupis exploring a take-private transaction, Insurance Insider reportsRegenxbioChief Executive Curran Simpson said the Food and Drug Administration has agreed to reverse its rejection of an experimental gene therapy for a rare and fatal brain disease, WSJ saysCharles Schwabis working with Cboe Global Marketsto roll out prediction market contracts that allow customers to place yes-or-no wagers on the performance of the S&P 500, WSJ reportsJohn Jumper is leaving GoogleDeepMind to join Anthropic, Reuters says4. MOVERS:Gettyincreases after entering aDefinium Therapeuticsgains after announcing its Emerge studyMoonLakehigher in New York after announcingfrom its Phase 3 VELA-1 and VELA-2 trialsSable Offshorelower after entering into aVirgin Galacticfalls after filing to exchange $52.5M in5. EARNINGS/GUIDANCE:Ennis, with EPS and revenue higher year-over-yearHawkEye, with EPS missing consensusFervo Energy, with EPS lower year-over-yearMicron Technologytoon June 24FedExtoon June 23INDEXES:The Dow rose 148.01, or 0.29%, to 51,712.71, the Nasdaq lost 351.33, or 1.32%, to 26,166.60, and the S&P 500 declined 27.79, or 0.37%, to 7,472.79.

MLTX Monitor News

MoonLake Prices $200M Public Offering Amid Strong Phase 3 Data

Jun 24 2026

MoonLake Immunotherapeutics Seeks BLA for Sonelokimab

Jan 09 2026

MoonLake Immunotherapeutics surges amid sector rotation

Jan 08 2026

MLTX.O Hits 20-Day High Amid Class Action Concerns

Nov 18 2025

MLTX Earnings Analysis

No Data

No Data

People Also Watch